Alternative simplified credit
10%
- Base
- Prior 3 years' QREs ÷ 6
- Zero prior year
- Full current QREs
- Form 306
- Part IV
State research · Northeast
Program status: Current · 10% Incremental Credit · Form 306
Yes. New Jersey offers a Research and Development Tax Credit against the Corporation Business Tax under N.J.S.A. 54:10A-5.24, claimed on Form 306. The credit is 10% of the sum of qualifying energy research consortium payments, basic research payments over their base amount, and New Jersey qualified research expenses over a base computed with the same method (regular or alternative simplified) the taxpayer used for its federal credit. Only research conducted in New Jersey qualifies. The credit cannot reduce tax below the minimum tax, is not refundable, and unused credit carries forward 7 privilege periods — 15 for research in six statutory technology fields.
Note: Current · Verified · Calculator verified — rules last verified October 7, 2026 for privilege periods 2025–2026 against the 2025 Form 306 and TB-114(R) (revised November 25, 2025).
Key takeaway
New Jersey's credit is 10% of an incremental amount: New Jersey QREs above a base (computed the same way — regular or ASC — as the taxpayer's federal credit), plus basic research payments above their base and qualifying energy research consortium payments. It is a Corporation Business Tax credit, applies only to research in New Jersey, cannot take tax below the minimum tax, and is not refundable.
10% of the INCREMENT · same method as federal · NJ research only · minimum tax floor · not refundable · 7 or 15 years
Yes. New Jersey's Research and Development Tax Credit is a current Corporation Business Tax (CBT) credit under N.J.S.A. 54:10A-5.24 and N.J.A.C. 18:7-3.23, claimed on Form 306. It is available to corporations filing CBT-100, CBT-100S and CBT-100U returns, and partnerships compute it for their corporate partners. It is not a Gross Income Tax or BAIT credit. The credit is 10% of an incremental amount computed with the same method — regular or alternative simplified credit (ASC) — that the taxpayer used for its federal research credit, and only research conducted in New Jersey qualifies.
The federal R&D tax credit is a separate credit under IRC §41 and is not affected by New Jersey’s state-level status. See how states are classified.
| Item | New Jersey |
|---|---|
| Program | Research and Development Tax Credit |
| Status | Current |
| Tax | Corporation Business Tax (not Gross Income Tax or BAIT) |
| Rate | 10% of the incremental amount |
| Credit formula | 10% × (energy consortium + basic research excess + QRE credit base) |
| Method | Regular or ASC — the same method used for the federal credit |
| Research location | New Jersey only |
| Form | Form 306, with a copy of federal Form 6765 |
| Limitation | Cannot reduce tax below the minimum tax |
| Refundable | No |
| Carryforward | 7 privilege periods (15 for six statutory fields) |
| Separate application | No |
| Administrator | New Jersey Division of Taxation |
10%
10%
Source: N.J.S.A. 54:10A-5.24 — Research and development credit, as amended by P.L. 2018, c.48 (A4202) (official external site, opens in a new tab) · Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · Corporation Business Tax credits and incentives (official external site, opens in a new tab)
New Jersey credit = 10% × (energy research consortium amount + basic research excess + research expense credit base).
| Form 306 part | Amount |
|---|---|
| Part I | Amounts paid to an energy research consortium (from 2018) |
| Part II | Basic research payments over the qualified organization base period amount |
| Part III or IV | QRE credit base — regular (Part III) or ASC (Part IV) |
| Part V | Total × 10% |
| Part VI / VII | Allowable credit after the tax limitation (Part VII for CBT-100U) |
The credit is not a flat 10% of all qualified research expenses. Taxpayers must use the same method — regular or alternative simplified credit — that they used for the federal research credit on Form 6765, and must enclose a copy of the federal Form 6765 as filed.
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · N.J.S.A. 54:10A-5.24 — Research and development credit, as amended by P.L. 2018, c.48 (A4202) (official external site, opens in a new tab)
If the taxpayer had no QREs in any one of the 3 preceding years, Form 306 directs it to skip lines 22 and 23 and enter the full current-year QREs (line 20) on line 24. The ASC base is not divided by 6 in that case. Unlike the federal ASC, New Jersey does not use a 14% / 6% rate: the 10% New Jersey rate applies to the result.
Illustrative only — before the tax limitation.
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab)
| Taxpayer | Fixed-base percentage |
|---|---|
| Existing company | Aggregate QREs ÷ aggregate gross receipts for tax years beginning after 1983 and before 1989 |
| Start-up company — first 5 tax years | 3% |
| Start-up company — later years | Form 306 start-up formulas |
| All companies | Rounded to 1/100th of 1% (four decimal places); cannot exceed 16% |
Illustrative only — before the tax limitation.
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab)
Basic research: 10% × (basic research payments − qualified organization base period amount), not less than zero. Basic research payments follow the federal IRC §41(e) concepts: cash payments under a written agreement to a qualified organization (such as a university) for basic research, for research in New Jersey.
Energy research consortia: for privilege periods beginning on or after January 1, 2018, amounts paid or incurred — including as contributions — to an energy research consortium for energy research also qualify as basic research payments. Confirm that the recipient is a qualifying New Jersey energy research consortium and that the payment is for energy research before including it.
Source: N.J.S.A. 54:10A-5.24 — Research and development credit, as amended by P.L. 2018, c.48 (A4202) (official external site, opens in a new tab) · Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab)
New Jersey uses the federal IRC §41 and §174 (or §174A) definitions and case law for qualified research and QREs. The QRE categories on Form 306 are:
| Situation | New Jersey treatment |
|---|---|
| Expenses taken for the federal Orphan Drug Credit | Excluded from the New Jersey credit |
| Expenses used for another New Jersey credit (for example recycling equipment, manufacturing equipment and employment investment, new jobs investment or angel investor credits) | Used for one credit only — no double use |
| Qualified small business payroll tax credit election (IRC §41(h)(3); §3111(f)), 2020 and later | QREs disallowed federally because of the election are still allowed for New Jersey |
Source: Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab)
Only qualified research conducted in New Jersey counts. There are two ways to determine New Jersey QREs:
Research by remote employees or contractors outside New Jersey is not New Jersey research. See research location.
The R&D credit, together with any other credits taken, cannot reduce the Corporation Business Tax below the statutory minimum tax. For privilege periods beginning on or after January 1, 2012 there is no separate 50%-of-liability limit. Credits are applied in the order of the privilege periods in which they were allowed, so older carryforwards are used first.
Room for the credit = CBT liability − minimum tax − other credits. Allowable credit = the lesser of the credit available and that room (zero if the room is zero or less). The rest carries forward.
| New Jersey gross receipts | CBT-100 | CBT-100S |
|---|---|---|
| Less than $100,000 | $500 | $375 |
| $100,000 to less than $250,000 | $750 | $562 |
| $250,000 to less than $500,000 | $1,000 | $750 |
| $500,000 to less than $1,000,000 | $1,500 | $1,125 |
| $1,000,000 or more | $2,000 | $1,500 |
A taxpayer that is a member of an affiliated or controlled group (IRC §1504 or §1563) with total payroll of $5,000,000 or more for the period pays a $2,000 minimum tax regardless of its New Jersey gross receipts. Combined groups apply the credit against the group's liability on Form 306 Part VII.
Illustrative only.
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · 2025 CBT-100 Instructions (Corporation Business Tax return) (official external site, opens in a new tab) · 2025 CBT-100S Instructions (S corporation return) (official external site, opens in a new tab) · 2025 CBT-100U Instructions (combined unitary return) (official external site, opens in a new tab)
Credit that cannot be used because of the limitation carries forward to the 7 privilege periods following the period in which it was allowed.
A 15-period carryforward applies to credit for research conducted in New Jersey in the fields of:
The longer period depends on the field of the research itself, not on an industry label. Carryovers cannot be claimed if Form 306 was never filed with a timely original or amended return for the year the credit arose, and the Division cannot adjust carryovers that were not properly filed.
Source: N.J.S.A. 54:10A-5.24 — Research and development credit, as amended by P.L. 2018, c.48 (A4202) (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab)
No. For privilege periods beginning on or after January 1, 2018, the credit is not refundable. Unused credit carries forward instead. Eligible technology and biotechnology companies may be able to sell unused credits through the separate NJEDA program described below, subject to its eligibility rules and annual application limits.
Source: N.J.S.A. 54:10A-5.24 — Research and development credit, as amended by P.L. 2018, c.48 (A4202) (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab)
| Entity | Treatment |
|---|---|
| C corporation (CBT-100) | Computes and uses the credit on Form 306 Part VI |
| Combined group (CBT-100U) | Members earn the credit and may share it with the group or elect not to share; the allowable credit is computed on Part VII against the group's liability |
| Partnership (NJ-1065) | Completes Form 306 Parts I–V; each corporate partner claims its share, shown on Schedule NJK-1, on its own Form 306 |
| S corporation or QSSS (CBT-100S) | Entitled to the credit against its own CBT; the credit does not pass through to shareholders and is often carried forward because of the minimum tax |
| Disregarded entity | Credit attributes belong to the owner |
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · 2025 CBT-100U Instructions (combined unitary return) (official external site, opens in a new tab)
New Jersey's latest published Form 306 is currently the 2025 version. Use the version corresponding to the applicable tax period when filing.
Source: Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · Corporation Business Tax credits and incentives (official external site, opens in a new tab)
New Jersey has a four-year statute of limitations for refunds and assessments. A taxpayer amending a return to claim the credit must use the Form 306 for the tax year being amended — for example, a 2023 Form 306 cannot be used for a 2019 credit. This is a filing/statute-of-limitations issue, not a statement that every taxpayer can automatically amend four years of returns.
Carryovers of credit for a year in which Form 306 was never filed with a timely original or amended return cannot be used in later years. See amended R&D claims for the federal side.
New Jersey denies a deduction for research expenditures used for the New Jersey credit unless they are also used for a federal IRC §41 credit. For privilege periods beginning on and after January 1, 2022, P.L. 2023, c.96 allows a taxpayer that claims both the New Jersey and federal credits to deduct its qualifying New Jersey research expenditures in the same privilege period as the New Jersey credit, notwithstanding the federal §174 amortization schedule. The deduction is reported as an other deduction on Schedule A, Part II.
| Item | Rule |
|---|---|
| Federal credit | IRC §41 on Form 6765 |
| Federal deduction timing | §174 / §174A |
| New Jersey credit | N.J.S.A. 54:10A-5.24 on Form 306 |
| New Jersey deduction timing | Same period as the NJ credit for NJ expenditures; non-NJ expenditures follow federal timing |
TB-114(R), revised November 25, 2025, explains that New Jersey conforms to the One Big Beautiful Bill Act timing rules for research deductions, with differences reconciled under N.J.S.A. 54:10A-4(k)(11). The deduction affects taxable income, not the credit calculation.
Source: Timing of New Jersey Qualified Research Expenditures (official external site, opens in a new tab) · P.L. 2023, c.96 — research and experimental expenditure deduction timing (official external site, opens in a new tab) · Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab)
The New Jersey Economic Development Authority's Technology Business Tax Certificate Transfer (NOL) Program lets eligible technology and biotechnology businesses with fewer than 225 full-time U.S. employees sell unused net operating losses and unused R&D tax credits to unrelated, profitable New Jersey corporate taxpayers for at least 80% of the value of the tax benefit.
It is a separate NJEDA program with its own eligibility requirements (including New Jersey headquarters and employee tests) and annual application window. The 2026 application deadline was June 30, 2026, and that cycle is closed. Check NJEDA for the next cycle.
Source: Technology Business Tax Certificate Transfer (NOL) Program (official external site, opens in a new tab) · NOL Program at a glance (updated June 29, 2026) (official external site, opens in a new tab)
Senate Bill 3560, introduced February 19, 2026, would raise the QRE credit to 15% for taxpayers in targeted industries, raise the basic research credit to 15% and make the credit refundable. It is an introduced bill and does not change current law: the 10% non-refundable credit described on this page continues to apply.
The New Jersey credit borrows the federal R&D tax credit definitions and method choice, but it is a separate state credit: it uses New Jersey QREs only, a 10% rate, New Jersey's minimum-tax limitation and its own carryforward. It is unrelated to the federal payroll tax credit election except that QREs disallowed federally because of that election still count in New Jersey. Estimate the federal credit with the federal R&D calculator, and compare New Jersey with New York, Pennsylvania and other states in the state R&D credit comparison.
Source: Technical Bulletin TB-114(R), The New Jersey Research and Development Tax Credit (revised November 25, 2025) (official external site, opens in a new tab) · Form 306, Research and Development Tax Credit (2025) and instructions (official external site, opens in a new tab)
The credit is available to any Corporation Business Tax taxpayer with qualified research in New Jersey, including pharmaceutical, life sciences, chemical, software and manufacturing companies. Industry matters only for the 15-year carryforward, and even then the research itself must be in one of the six statutory fields.
Each entry applies to the tax years shown. Rules are kept when the law changes, so earlier years remain visible.
10% of the energy consortium amount, basic research excess and QRE credit base; same method as federal (regular or ASC); New Jersey research only; cannot reduce tax below the minimum tax; not refundable; 7- or 15-year carryforward. From 2022, NJ research expenditures are deducted in the same period as the NJ credit when both credits are claimed.
Research performed in New Jersey may still qualify for the federal R&D tax credit under IRC §41 if the taxpayer and the research activities satisfy the federal requirements, including the four-part test and the rules for qualified research expenses.
New Jersey uses the method and definitions of the federal R&D tax credit under IRC §41. See the four-part test, qualified research expenses, §174 and §174A, Form 6765, the federal R&D calculator, the New Jersey R&D calculator, all calculators, forms, the state R&D credit comparison and the state directory, including Northeast neighbors New York, Pennsylvania, Connecticut and Delaware.
Verified for tax years 2025, 2026. Results are estimates that show every intermediate value.
Open the New Jersey R&D Tax Credit CalculatorYes. New Jersey offers a Research and Development Tax Credit against the Corporation Business Tax under N.J.S.A. 54:10A-5.24, claimed on Form 306.
10% of an incremental amount: the energy research consortium amount, plus basic research payments over their base, plus New Jersey QREs over the regular or ASC base.
No. The 10% rate applies to QREs above a base amount (plus basic research excess and energy consortium amounts), not to total QREs.
10% × (energy consortium amount + basic research payments over the base period amount + QRE credit base), computed on Form 306 Parts I–V, then limited by the minimum tax in Part VI or VII.
The same method — regular or alternative simplified credit — that the taxpayer used for its federal research credit on Form 6765.
Credit base = current New Jersey QREs minus one-sixth of the QREs for the 3 preceding years. Example: $1,000,000 current and $600,000 prior → $900,000 credit base → $90,000 credit.
Form 306 says to skip the ASC base lines and enter the full current-year QREs as the credit base, so the 10% rate applies to all current New Jersey QREs.
Base amount = fixed-base percentage × average gross receipts of the 4 preceding years, but not less than 50% of current QREs. Credit base = current QREs − base amount.
For existing companies, 1984–1988 QREs divided by 1984–1988 gross receipts; for start-ups, 3% in the first 5 tax years and then the Form 306 formulas. It is rounded to four decimal places and capped at 16%.
Wages for qualified services, supplies, rental or lease of computers, and 65% of contract research, for qualified research under IRC §41 conducted in New Jersey.
Yes. Only research conducted in New Jersey qualifies. Taxpayers that cannot determine their New Jersey QREs may use a three-factor allocation of property, payroll and receipts.
QREs everywhere are multiplied by a fraction of New Jersey property, payroll and receipts over property, payroll and receipts everywhere. It is for taxpayers that cannot determine New Jersey QREs directly.
Yes. 10% of basic research payments to qualified organizations above the qualified organization base period amount, using IRC §41(e) concepts.
For privilege periods beginning on or after January 1, 2018, amounts paid to an energy research consortium for energy research qualify as basic research payments.
No. Expenses taken for the federal Orphan Drug Credit cannot be used for the New Jersey R&D credit.
No. Expenses used for the R&D credit cannot be used for any other New Jersey credit, and vice versa.
For privilege periods from 2020, QREs of a qualified small business disallowed for the federal income tax credit because of the payroll tax election are still allowed for New Jersey.
No. It is not refundable for privilege periods beginning on or after January 1, 2018.
No. The R&D credit and other credits cannot reduce the Corporation Business Tax below the statutory minimum tax.
For CBT-100 filers $500 to $2,000 and for CBT-100S filers $375 to $1,500, based on New Jersey gross receipts; $2,000 for members of affiliated or controlled groups with total payroll of $5 million or more.
Seven privilege periods, or 15 for credit from research in advanced computing, advanced materials, biotechnology, electronic device technology, environmental technology or medical device technology.
No. The research itself must be in one of the six statutory fields; an industry label alone is not enough.
Credits are applied in the order of the privilege periods in which they were allowed, so older carryforwards are used first.
Yes, against their own CBT, but the credit does not pass through to shareholders. Because of the minimum tax it is often carried forward.
The partnership completes Form 306 Parts I–V; each corporate partner claims its share, shown on Schedule NJK-1, on its own Form 306 and CBT return.
Members earn the credit and may share it with the combined group or elect not to share it. The allowable credit is computed on Form 306 Part VII against the group's liability.
No. It is a Corporation Business Tax credit. Individuals and pass-through owners do not claim it on Gross Income Tax or BAIT returns.
Form 306 for the applicable privilege period, attached to the CBT return with a copy of federal Form 6765. The latest published Form 306 is the 2025 version.
Possibly, within New Jersey's four-year statute of limitations, using the Form 306 for the year being amended. This is a filing/statute-of-limitations issue, not a statement that every taxpayer can automatically amend four years of returns.
Carryovers from a year in which Form 306 was never filed with a timely original or amended return cannot be claimed in later years.
If both the New Jersey and federal credits are claimed, qualifying New Jersey research expenditures are deducted in the same privilege period as the New Jersey credit, notwithstanding §174. Non-New Jersey expenditures follow federal timing.
Possibly, through NJEDA's Technology Business Tax Certificate Transfer Program for eligible technology and biotechnology companies with fewer than 225 U.S. employees. The 2026 application window closed June 30, 2026.
No. S3560 was introduced February 19, 2026; it does not change current law.
Yes. The New Jersey R&D calculator follows Form 306: regular or ASC, basic research, energy consortium, the minimum-tax limitation and the 7- or 15-year carryforward. Results are estimates.
No. ResearchTaxCredits.org is an independent research and educational website and is not affiliated with the State of New Jersey, the Division of Taxation or NJEDA.
New Jersey Legislature · N.J.S.A. 54:10A-5.24; P.L. 2018, c.48
Supports: Credit of 10% of the excess of qualified research expenses over the base amount and 10% of basic research payments; amounts paid to an energy research consortium for energy research qualify as basic research payments for privilege periods beginning on and after January 1, 2018; not refundable for privilege periods beginning on or after January 1, 2018; unused credit carried over to the 7 following privilege periods, or 15 for research in advanced computing, advanced materials, biotechnology, electronic device technology, environmental technology and medical device technology.
New Jersey Division of Taxation · Form 306 (2025)
Supports: Part I energy consortia; Part II basic research payments; Part III regular method (fixed-base percentage rounded to four decimal places and capped at 16%, existing companies 1984–1988 ratio, start-ups 3% for the first 5 tax years, base not less than 50% of current QREs, average gross receipts of the 4 preceding years); Part IV alternative simplified credit (QREs for the prior 3 years ÷ 6; if any of those years had no QREs, skip lines 22–23 and enter line 20 on line 24); contract research at 65%; Orphan Drug Credit expenses excluded; same method as the federal credit with Form 6765 enclosed; 10% credit rate; Part VI allowable credit for CBT-100 and CBT-100S filers and Part VII for CBT-100U filers (members may elect not to share); partnerships complete Parts I–V and corporate partners claim their share from Schedule NJK-1; credit cannot reduce tax below the statutory minimum.
New Jersey Division of Taxation · TB-114(R)
Supports: Same method as the federal credit; 10% of NJ qualifying research expenditures and 10% of basic research payments for research in New Jersey; energy consortium payments qualify; three-factor (property, payroll, receipts) allocation when NJ QREs cannot be determined, including for combined groups; qualified small business payroll tax credit election expenses allowed from 2020; expenses used for the R&D credit cannot be used for any other NJ credit; 7-year carryforward and 15-year carryforward for the statutory fields; not refundable; S corporations and QSSSs carry the credit forward; four-year statute of limitations, amended returns on the Form 306 for the year involved, and carryovers unavailable if Form 306 was never filed with a timely original or amended return; revised for the OBBBA effect on research deduction timing.
Corporation Business Tax credits and incentives (official external site, opens in a new tab)
New Jersey Division of Taxation
Supports: Lists the Research and Development Tax Credit (Form 306) among Corporation Business Tax credits.
Timing of New Jersey Qualified Research Expenditures (official external site, opens in a new tab)
New Jersey Division of Taxation
Supports: P.L. 2023, c.96 (July 3, 2023) amended N.J.S.A. 54:10A-4(k)(11): taxpayers claiming the CBT R&D credit for NJ qualified research expenditures deduct them in the same year as the credit (reported as other deductions on Schedule A, Part II); non-NJ qualified research expenditures follow federal timing; New Jersey conforms to the OBBBA timing rules and differences are reconciled under N.J.S.A. 54:10A-4(k)(11).
New Jersey Legislature · P.L. 2023, c.96; N.J.S.A. 54:10A-4(k)(11)
Supports: No deduction for research expenditures for which the NJ credit is claimed unless they are also used for the federal IRC §41 credit; for privilege periods beginning on and after January 1, 2022, the deduction is allowed in the same privilege period as the NJ credit, notwithstanding the IRC §174 timing schedule.
New Jersey Division of Taxation · CBT-100 instructions (2025)
Supports: Minimum tax by New Jersey gross receipts: under $100,000 $500; $100,000–$249,999 $750; $250,000–$499,999 $1,000; $500,000–$999,999 $1,500; $1,000,000 or more $2,000; $2,000 for members of an affiliated or controlled group with total payroll of $5,000,000 or more.
2025 CBT-100S Instructions (S corporation return) (official external site, opens in a new tab)
New Jersey Division of Taxation · CBT-100S instructions (2025)
Supports: S corporation minimum tax by New Jersey gross receipts: under $100,000 $375; $100,000–$249,999 $562; $250,000–$499,999 $750; $500,000–$999,999 $1,125; $1,000,000 or more $1,500; $2,000 for members of an affiliated or controlled group with total payroll of $5,000,000 or more.
2025 CBT-100U Instructions (combined unitary return) (official external site, opens in a new tab)
New Jersey Division of Taxation · CBT-100U instructions (2025)
Supports: Combined group filing; tax credits are earned by members and applied against the combined group liability, computed on Form 306 Part VII.
Technical bulletins index (official external site, opens in a new tab)
New Jersey Division of Taxation
Supports: Lists TB-114(R), revised November 25, 2025.
New Jersey Economic Development Authority
Supports: Technology and biotechnology businesses with fewer than 225 full-time U.S. employees may sell unused net operating losses and unused R&D tax credits for at least 80% of their value to unrelated profitable New Jersey corporate taxpayers; the 2026 application deadline was June 30, 2026 at 11:59 p.m.
NOL Program at a glance (updated June 29, 2026) (official external site, opens in a new tab)
New Jersey Economic Development Authority
Supports: Eligibility summary: fewer than 225 full-time U.S. employees on a total corporate basis; New Jersey headquarters or base of operations and minimum full-time New Jersey employees by company age; sale for at least 80% of the tax benefit.
New Jersey Legislature · S3560 (introduced February 19, 2026)
Supports: Introduced bill that would raise the QRE credit to 15% for targeted industries, raise the basic research credit to 15% and make the credit refundable. It is an introduced bill; it does not change current law, and the 2025 Form 306 and TB-114(R) describe the 10%, non-refundable credit.
Current law: N.J.S.A. 54:10A-5.24 (as amended by P.L. 2018, c.48) and N.J.A.C. 18:7-3.23. Administrative guidance: the 2025 Form 306 and instructions, TB-114(R) (revised November 25, 2025), the Division's deduction-timing guidance and the 2025 CBT-100, CBT-100S and CBT-100U instructions. The NJEDA program and S3560 are shown separately as a related program and an introduced bill. Verified October 7, 2026.
Verified October 7, 2026 for privilege periods 2025–2026 against N.J.S.A. 54:10A-5.24 (as amended by P.L. 2018, c.48), the 2025 Form 306 and instructions, Technical Bulletin TB-114(R) (revised November 25, 2025), the Division of Taxation's guidance on the timing of New Jersey qualified research expenditures (P.L. 2023, c.96), the 2025 CBT-100, CBT-100S and CBT-100U instructions, and NJEDA's Technology Business Tax Certificate Transfer Program materials.
How research is conducted: methodology · state research coverage.